Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 16.41 M20.56 M20.23 M17.59 M 74.78 M Research & development 165 K——-82 K — Operating income -20.97 M-21 M-20.66 M-19.35 M -81.98 M Non-Operating Income, Total 44 K1.39 M4 000-2.78 M -1.34 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 44 K1.39 M4 000-2.78 M -1.34 M Unusual income/expense ———— — Pretax income 6.1 M2.81 M9.12 M17.49 M 35.52 M Equity in earnings ———— — Taxes 1.03 M984 K2.01 M3.01 M 7.04 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 5.07 M1.83 M7.11 M14.48 M 28.48 M Discontinued operations 591 K-97 K-35 K93 K 552 K Net income 5.66 M1.73 M7.07 M14.57 M 29.04 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 5.66 M1.73 M7.07 M14.57 M 29.04 M Basic earnings per share (Basic EPS) 0.170.050.20.42 0.84 Diluted earnings per share (Diluted EPS) 0.170.050.20.42 0.84 Average basic shares outstanding 34.7 M34.77 M34.77 M34.74 M — Diluted shares outstanding 34.7 M34.77 M34.77 M34.74 M — EBITDA -169.32 M-172.32 M-180.36 M-159.91 M -681.91 M EBIT -179.87 M-177.69 M-185.82 M-166.6 M -709.98 M Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 10.54 M5.37 M5.46 M6.69 M 28.07 M